Premium
[DT‐01–02]: THE IMPACT OF AMYLOID PET ON DIAGNOSIS AND PATIENT MANAGEMENT IN AN UNSELECTED MEMORY CLINIC COHORT: THE ABIDE PROJECT
Author(s) -
Wilde Arno,
Pelkmans Wiesje,
Bouwman Femke H.,
Verwer Jurre,
Groot Colin,
Buchem Marieke,
Zwan Marissa D.,
Ossenkoppele Rik,
Yaqub Maqsood M.,
Kunneman Marleen,
Smets Ellen M.,
Barkhof Frederik,
Lammertsma Adriaan A.,
Stephens Andrew,
Lier Erik,
Biessels Geert Jan,
Berckel Bart N.M.,
Flier Wiesje M.,
Scheltens Philip
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.08.004
Subject(s) - medicine , etiology , cohort , dementia , confidence interval , amyloid (mycology) , memory clinic , pediatrics , pathology , disease
DT-01-01 IMPACT OFAMYLOID PET ON PATIENT MANAGEMENT: EARLY RESULTS FROM THE IDEAS STUDY Gil D. Rabinovici, Constantine Gatsonis, Charles Apgar, Ilana F. Gareen, LucyHanna, James Hendrix, Bruce E. Hillner, Cynthia Olson, Justin Romanoff, Barry A. Siegel, Rachel A. Whitmer, Maria C. Carrillo, the IDEAS Study investigators, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA; Department of Biostatistics, Brown University, Providence, RI, USA; American College of Radiology Imaging Network, Philadelphia, PA, USA; Alzheimer’s Association, Chicago, IL, USA; Department of Medicine, VirginiaCommonwealth University, Richmond, VA,USA; Department of Radiology, Washington University, St. Louis, MO, USA; Kaiser PermanenteDivision of Research,Oakland, CA, USA. Contact e-mail: Gil.Rabinovici@ucsf.edu